חובות לטווח קצר של החברה: apyxmedical.com (APYX)

Apyx Medical (APYX) is scaling its capital through partnerships with aesthetic centers to implement Renuvion. The GURU.Markets terminal displays a chart of short-term loan sizes, where the 0.00 mark captures this metric. However, fierce competition with laser suppliers for the tissue healing market and FDA regulatory claims regarding the safety of rejuvenation systems create risks for margins and sales.

Short-term debt measures the volume of obligations with a maturity horizon of up to one year, reflecting liquidity and the company's ability to service current loans through operating cash flow. By analyzing the short-term debt portfolio, an investor assesses the financial stability of Apyx Medical (APYX) in the context of scaling helium-plasma technologies, where the balance of borrowings determines the speed of implementing new clinical approvals without the risk of losing solvency.